Reporting of suspected adverse reactions to drugs by means of the yellow card
Section: Cover story
How to quote
Salcedo de Diego I, Ruiz Antorán B, Sancho López A, Cabrera García L. Notificación de sospecha de reacciones adversas a medicamentos mediante la tarjeta amarilla. Metas de Enferm dic 2009/ene 2010; 12(10): 24-29
Authors
1Isabel Salcedo de Diego, 2Belén Ruiz Antorán, 2Arantxa Sancho López, 2Lourdes Cabrera García
Position
1Diplomada en Enfermería. Máster en Salud Pública y Epidemiología. Servicio de Farmacología Clínica. Hospital Universitario Puerta de Hierro, Majadahonda (Madrid).2Enfermera. Unidad de Psiquiatría infantil. Hospital Universitario Puerta de Hierro, Majadahonda.
Contact address
Servicio de Farmacología Clínica. Hospital Universitario Puerta de Hierro. C/ Manuel de Falla, 1. 28220 Majadahonda (Madrid)
Contact email: isalcedo.hpth@salud.madrid.org
Abstract
Adverse reactions to drugs (ARD) are a public health problem in our society. It is estimated that in western countries, 5,3% of hospital admissions are associated with ARD, 6,7% of hospitalised patients suffer from severe ARD and that this problem accounts for 5-9% of intrahospital cost. Despite the fact that spontaneous reporting of suspected ARD via the “Yellow Card” is the most efficient method for the detection of new and/or severe adverse reactions to drugs, it is estimated that only about 10% are reported. Spanish legislation stipulates that all health care professionals are mandatory reporters of suspected adverse reactions to authorised drugs. However, in 2006, nurses contributed only 3% of all Yellow Cards to the Spanish System of Drug Surveillance. The underreporting of ARD on the part of nursing professionals is a phenomenon pending future study.
Keywords:
adverse Reactions to Drugs (ARD); spontaneous reporting; yellow card; drug surveillancereview
Versión en Español
Título:
Notificación de sospecha de reacciones adversas a medicamentos mediante la tarjeta amarilla